A Comparative Trial of Zidovudine Administered Every Four Versus Every Twelve Hours for the Treatment of Advanced HIV Disease-Reference-Cited by-同舟云学术

A Comparative Trial of Zidovudine Administered Every Four Versus Every Twelve Hours for the Treatment of Advanced HIV Disease

Published:1997-08 Issue:4 Volume:15 Page:283-288
ISSN:1077-9450
Container-title:Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
language:en
Short-container-title:Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Author:

Shepp David H.,Ramirez-Ronda Carlos,Dall Lawrence,Pollard Richard B.,Murphy Robert L.,Kessler Harold,Sherer# Renslow,Mertz Gregory,Perez George,Gocke David J.,Greenberg Stephen B.,Petersen Eskild,Frank Ian,Moore## Mark D.,McKinnis## Ray,Rooney## James F.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Virology,Immunology,Immunology and Allergy

Reference33 articles.

1. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.

2. EFFECT OF ZIDOVUDINE ON SERUM HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN LEVELS IN SYMPTOM-FREE SUBJECTS

3. Reduction in plasma human immunodeficiency virus ribonucleic acid after dideoxynucleoside therapy as determined by the polymerase chain reaction.

4. Reconstitution of Long-Term T Helper Cell Function after Zidovudine Therapy in Human Immunodeficiency Virus-Infected Patients

5. Augmentation of Cellular Immune Function during the Early Phase of Zidovudine Treatment of AIDS Patients

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic–pharmacodynamic relationship of NRTIs and its connection to viral escape: An example based on zidovudine;European Journal of Pharmaceutical Sciences;2009-03

2. Intracellular Pharmacokinetics of Once versus Twice Daily Zidovudine and Lamivudine in Adolescents;Antimicrobial Agents and Chemotherapy;2007-10

3. Intensive Pharmacokinetics of Zidovudine 200 mg Twice Daily in HIV-1-Infected Patients Weighing Less Than 60 kg on Highly Active Antiretroviral Therapy;JAIDS Journal of Acquired Immune Deficiency Syndromes;2006-07

4. The impact of reducing dose frequency on health outcomes;Clinical Therapeutics;2003-08

5. Tolerabilities of Antiretrovirals in Paediatric HIV Infection;Drug Safety;2002